NovAccess Global Inc. (OTCMKTS:XSNX – Get Rating) was the recipient of a significant drop in short interest in January. As of January 31st, there was short interest totalling 3,900 shares, a drop of 25.0% from the January 15th total of 5,200 shares. Based on an average daily trading volume, of 8,000 shares, the short-interest ratio is currently 0.5 days.
NovAccess Global Price Performance
Shares of XSNX stock traded up $0.04 during trading hours on Friday, reaching $0.20. The company had a trading volume of 28,594 shares, compared to its average volume of 4,748. The stock has a fifty day moving average of $0.21 and a 200-day moving average of $0.20. NovAccess Global has a 12-month low of $0.10 and a 12-month high of $0.60.
Get NovAccess Global alerts:About NovAccess Global
(Get Rating)
NovAccess Global, Inc is a biopharmaceutical company, which engages in the provision of diagnostics, therapeutics in cancer, and neurological diseases and the development of immunotherapies to treat brain tumor patients. The company was founded on February 25, 1997 and is headquartered in Cuyahoga County, OH.Featured Stories
- Get a free copy of the StockNews.com research report on NovAccess Global (XSNX)
- MarketBeat Week in Review – 2/6 – 2/10
- Will Snowflake Have Tough Sledding, Trying To Keep Rally Alive?
- The Bottom Is In For Cloudflare Stock
- 3 Tickers Leading a Meme Stock Revival
- Microsoft-Activision Blizzard Merger: Navigating Risk and Reward
Receive News & Ratings for NovAccess Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovAccess Global and related companies with MarketBeat.com's FREE daily email newsletter.